UK investigates two adverse reactions to Pfizer jab, says people with history of serious allergic reactions shouldn't get inoculated
Professor Stephen Powis, national medical director for the National Health Service in England, said the condition of the two people who received the vaccine are recovering well
London: UK regulators said Wednesday that people who have a “significant history" of allergic reactions shouldn’t receive the new Pfizer-BioNTech vaccine while they investigate two adverse reactions that occurred on the first day of the country’s mass vaccination programme.
Professor Stephen Powis, national medical director for the National Health Service in England, said health authorities were acting on a recommendation from the Medical and Healthcare Products Regulatory Agency.
“As is common with new vaccines the MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination after two people with a history of significant allergic reactions responded adversely yesterday," Powis said in a statement.
“Both are recovering well.”
The comments came as Dr June Raine, head of the MHRA, told a Parliamentary committee that regulators had received reports of two allergic reactions from the vaccine.
“We know from the very extensive clinical trials that this wasn’t a feature,” she said.
“But If we need to strengthen our advice, now that we have had this experience with the vulnerable populations, the groups who have been selected as a priority, we get that advice to the field immediately.
Raine’s comments came as part of a general discussion of how her agency will continue to monitor people who receive the vaccine authorised for emergency use last week.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
Second dry run for COVID-19 vaccination drive held in over 700 districts; Delhi govt issues SOPs for UK returnees
The number of people who have tested positive for the new UK variant of SARS-CoV-2 has climbed to 82 in India, the Centre said; the number of such people stood at 73 till 6 January
Coronavirus News Updates: Centre should bear cost of COVID-19 vaccine for the poor, says Rajesh Tope
Coronavirus News Updates: The Maharashtra health minister said two doses (of a COVID-19 vaccine) will cost Rs 500 and the state government will take "appropriate" steps if the Centre doesn't take steps regarding its expectation
Pfizer's Covid-19 vaccine found effective against UK, SA variants of SARS-CoV-2 virus, study reports
The study noted that the Pfizer–BioNTech shot worked against 15 additional possible mutations in the SARS-CoV-2 virus.